Sangamo Announces AAV Capsid Data

Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

BRISBANE, Calif. --(BUSINESS WIRE)--Feb. 18, 2021-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in the following investor conferences: Cowen 41 st Annual Health Care Conference Date: Monday, March 1 st at 2:40 p.m.